Abstract: A Flood Source for calibration of gamma-cameras comprises the nuclide Tellurium-123m in a solution contained uniformly within a liquid-retaining plastics sheet of uniform thickness. The plastics sheet may be enclosed in a protective metallic casing.
Type:
Grant
Filed:
January 24, 1975
Date of Patent:
July 5, 1977
Assignee:
The Radiochemical Centre Limited
Inventors:
Edgar Adolf Lorch, Keith Ernest Fletcher, David Page
Abstract: The invention provides a method and a kit for the saturation analysis of a steroid characterized by the use of a selenium-75 labelled version of the steroid to be assayed. Selenium-75 derivatives of steroids are quite simple to prepare and have practical advantages over other radioactively labelled steroids. Lists of derivatives and examples of competitive radio-assays are given.
Type:
Grant
Filed:
December 5, 1974
Date of Patent:
June 21, 1977
Assignee:
The Radiochemical Centre Limited
Inventors:
Russell James Bayly, Virginia Edith May Chambers, Reginald Monks
Abstract: Radio-iodine derivatives of digoxin and digitoxin are provided having the formula IV, whereR is H or lower alkyln is 1, 2 or 3Y is H or carboxylm is 0 to 5, andQ is a phenolic or imidazole ring,To which radio-iodine atoms are attached. Novel intermediates in the preparation of the radio-iodine derivative are described. The derivatives are useful for the radioimmunoassay of digoxin and digitoxin.
Type:
Grant
Filed:
June 19, 1975
Date of Patent:
June 14, 1977
Assignee:
The Radiochemical Centre Limited
Inventors:
Keith Charles Tovey, John William Addison Findlay
Abstract: Novel selenium-75 derivatives of cholesterol have the formula ##STR1## (I) where X is hydrogen or acyl, Y is alkyl and n is 0 or 1. They are useful for visualizing the adrenal glands of mammals.
Type:
Grant
Filed:
February 19, 1975
Date of Patent:
May 17, 1977
Assignee:
The Radiochemical Centre Limited
Inventors:
Reginald Monks, Anthony Leonard Mark Riley, Gavin Murray Cree
Abstract: In some radioimmunoassays, the antigen competes with labelled antigen for reaction with a first antibody and the antigen-antibody complex is precipitated by reaction with an aqueous solution of a second antibody to the first antibody. The invention consists in using an artificially colored second antibody, so that the precipitate is easily visible to the naked eye.
Abstract: Aqueous fluids for skeletal imaging comprise technetium-99m present as a bone-seeking technetium-99m/tin/phosphate complex, are prepared using a monofluorophosphate and stannous fluoride or chloride, the molar proportion of monofluorophosphate to stannous ion being from 30:1 to 500:1, to react with pertechnetate. Kits for skeletal imaging comprise mixture of monofluorophosphate with stannous ion for reaction with pertechnetate.
Abstract: The stability of fibrinogen is improved by mixing it with albumin, preferably at least 5 parts by weight of albumin per part by weight of fibrinogen. By this invention, iodinated (.sup.125 I) human fibrinogen can be stabilised with human serum albumin for use in the diagnosis of thrombi.
Type:
Grant
Filed:
June 19, 1973
Date of Patent:
January 20, 1976
Assignee:
The Radiochemical Centre Limited
Inventors:
John Cecil Charlton, David Lawrence Gravett